Compare LFMDP & MDCXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LFMDP | MDCXW |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | Canada |
| Employees | 384 | 12 |
| Industry | Medical/Nursing Services | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | N/A |
| Metric | LFMDP | MDCXW |
|---|---|---|
| Price | $23.75 | $0.53 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.2K | 2.1K |
| Earning Date | N/A | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $18.50 | $0.29 |
| 52 Week High | $24.78 | $3.50 |
| Indicator | LFMDP | MDCXW |
|---|---|---|
| Relative Strength Index (RSI) | 54.36 | 48.02 |
| Support Level | $23.48 | $0.44 |
| Resistance Level | $24.02 | $1.12 |
| Average True Range (ATR) | 0.18 | 0.06 |
| MACD | -0.05 | 0.01 |
| Stochastic Oscillator | 41.67 | 46.62 |
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.